Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 5, 2008, Pages 798-804

  Kooi, Elisabeth M W ^a   Schokker, Siebrig ^b   Marike Boezen, H ^b   de Vries, Tjalling W ^c   Vaessen Verberne, Anja A P H ^d   van der Molen, Thys ^b   Duiverman, Eric J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d AMPHIA HOSPITAL   (Netherlands)

Author keywords

Anti asthmatic agents; Child; Fluticasone; Forced oscillation technique; Interrupter technique; Lung function; Montelukast; Preschool

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALBUTAMOL;

AIRWAY RESISTANCE; ARTICLE; ASTHMA; CHICKENPOX; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEVICE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DYSPNEA; ECZEMA; EOSINOPHIL COUNT; GASTROENTERITIS; HUMAN; HYPERACTIVITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; METERED DOSE INHALER; MONOTHERAPY; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SAMPLE SIZE; SKIN INFECTION; SYMPTOM; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; WHEEZING;

ACETATES; ADMINISTRATION, ORAL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METERED DOSE INHALERS; NETHERLANDS; OUTPATIENT CLINICS, HOSPITAL; QUINOLINES; RESPIRATORY FUNCTION TESTS; TABLETS; TIME FACTORS; TREATMENT OUTCOME;

EID: 51049107468     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.06.004     Document Type: Article

References (39)

1. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., and Morgan W.J. Asthma and wheezing in the first six years of life. The group health medical associates. N Engl J Med 332 (1995) 133-138
2. National Institute of Health National Heart, Lung and Blood institute, Global Initiative for Asthma. NIH Publication Number 95-3659, Bethesda, USA, 1995.
3. Ostrom N.K., Decotiis B.A., Lincourt W.R., Edwards L.D., Hanson K.M., Carranza Jr. R., et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr 147 (2005) 213-220
4. Garcia Garcia M.L., Wahn U., Gilles L., Swern A., Tozzi C.A., and Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 116 (2005) 360-369
5. Ducharme F.M., and Hicks G.C. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev (2002) CD002314
6. Creticos P.S. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists. Drugs 63 Suppl. 2 (2003) 1-20
7. Zeiger R.S., Szefler S.J., Phillips B.R., Schatz M., Martinez F.D., Chinchilli V.M., et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117 (2006) 45-52
8. Bisgaard H., Allen D., Milanowski J., Kalev I., Willits L., and Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1-3 years with recurrent wheezing. Pediatrics 113 (2004) e87-e94
9. Pao C.S., and McKenzie S.A. Inhaled corticosteroids for persistent wheeze in preschool children. Am J Respir Crit Care Med 163 (2001) 1278
10. Guilbert T.W., Morgan W.J., Zeiger R.S., Mauger D.T., Boehmer S.J., Szefler S.J., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354 (2006) 1985-1997
11. Murray C.S., Woodcock A., Langley S.J., Morris J., and Custovic A. Secondary prevention of asthma by the use of inhaled fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 368 (2006) 754-762
12. Knorr B., Franchi L.M., Bisgaard H., Vermeulen J.H., LeSouef P., Santanello N., et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2-5 years. Pediatrics 108 (2001) E48
13. Bisgaard H., Zielen S., Garcia-Garcia M.L., Johnston S.L., Gilles L., Menten J., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171 (2005) 315-322
14. Davies G.M., Dasbach E.J., Santanello N.C., Knorr B.A., and Bratton D.L. The effect of montelukast versus usual care on health care resource utilization in children aged 2-5 years with asthma. Clin Ther 26 (2004) 1895-1904
15. Allen-Ramey F.C., Duong P.T., Riedel A.A., Markson L.E., and Weiss K.B. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline. Ann Allergy Asthma Immunol 93 (2004) 373-380
16. Nielsen K.G., and Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. Am J Respir Crit Care Med 162 (2000) 1500-1506
17. Straub D.A., Minocchieri S., Moeller A., Hamacher J., and Wildhaber J.H. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2-5 years old. Chest 127 (2005) 509-514
18. Bisgaard H., and Nielsen K.G. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med 162 (2000) 187-190
19. Schokker S., Kooi E.M., de Vries T.W., Brand P.L., Mulder P.G., Duiverman E.J., et al. Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial. Pulm Pharmacol Ther 21 (2008) 88-97
20. Merkus P.J.F.M., Mijnsbergen J.Y., Hop W.C.J., and De Jongste J.C. Interrupter resistance in preschool children-measurement characteristics and reference values. Am J Respir Crit Care Med 163 (2001) 1350-1355
21. McKenzie S.A., Bridge P.D., and Pao C.S. Lung function tests for pre-school children. Paediatr Respir Rev 2 (2001) 37-45
22. Oostveen E., MacLeod D., Lorino H., Farre R., Hantos Z., Desager K., et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 22 (2003) 1026-1041
23. Oswald-Mammosser M., Llerena C., Speich J.P., Donata L., and Lonsdorfer. Measurements of respiratory system resistance by the interrupter technique in healthy and asthmatic children. Pediatr Pulmonol 24 (1997) 78-85
24. Kooi E.M., Schokker S., van der Molen T., and Duiverman E.J. Airway resistance measurements in pre-school children with asthmatic symptoms: the interrupter technique. Respir Med 100 (2006) 955-964
25. van de Woestijne K.P., Desager K.N., Duiverman E.J., and Marchal F. Recommendations for measurement of respiratory input impedance by means of the forced oscillation method. Eur Respir Rev 4 (1994) 235-237
26. Clement J., Landser F.J., and van de Woestijne K.P. Total resistance and reactance in patients with respiratory complaints with and without airways obstruction. Chest 83 (1983) 215-220
27. Roorda R.J., Mezei G., Bisgaard H., and Maden C. Response of preschool children with asthma symptoms to fluticasone propionate. J Allergy Clin Immunol 108 (2001) 540-546
28. McKean M., and Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev (2000) CD001107
29. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., Boehmer S.J., Chinchilli V.M., Martinez F.D., et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the pediatric asthma controller trial. J Allergy Clin Immunol 119 (2007) 64-72
30. Jartti T. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?. Eur J Pediatr 167 (2008) 731-736
31. Bisgaard H., Gillies J., Groenewald M., and Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med 160 (1999) 126-131
32. Stelmach I., Jerzynska J., and Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 109 (2002) 257-263
33. Bisgaard H., Loland L., and Oj J.A. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 160 (1999) 1227-1231
34. Lebecque P., Spier S., Lapierre J.G., Lamarre A., Zinman R., and Coates A.L. Histamine challenge test in children using forced oscillation to measure total respiratory resistance. Chest 92 (1987) 313-318
35. Stanescu D., Moavero N.E., Veriter C., and Brasseur L. Frequency dependence of respiratory resistance in healthy children. J Appl Physiol 47 (1979) 268-272
36. Knorr B., Nguyen H.H., Kearns G.L., Villaran C., Boza M.L., Reiss T.F., et al. Montelukast dose selection in children ages 2-5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol 41 (2001) 612-619
37. Migoya E., Kearns G.L., Hartford A., Zhao J., van A.J., Tozzi C.A., et al. Pharmacokinetics of montelukast in asthmatic patients 6-24 months old. J Clin Pharmacol 44 (2004) 487-494
38. Duiverman E.J., Brackel H.J., Merkus P.J., Rottier B.L., and Brand P.L. Guideline 'Treating asthma in children' for pediatric pulmonologists (2nd revised edition). II. Medical treatment. Ned Tijdschr Geneeskd 147 (2003) 1909-1913
39. Helms P.J., and Amre D. Prognosis of wheezing and asthma presenting in early childhood. Breathe 1 (2004) 131-137